# Immunological Functionnal Test Validation to Predict Melanoma Metastatic Patient Response to Checkpoint Inhibitors

> **NCT05649683** · NA · RECRUITING · sponsor: **Centre Hospitalier Universitaire de Nice** · enrollment: 60 (estimated)

## Conditions studied

- Melanoma (Skin)

## Interventions

- **BIOLOGICAL:** Evaluation of cytokine production

## Key facts

- **NCT ID:** NCT05649683
- **Lead sponsor:** Centre Hospitalier Universitaire de Nice
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-01-31
- **Primary completion:** 2027-02-01
- **Final completion:** 2027-06-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2024-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05649683

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05649683, "Immunological Functionnal Test Validation to Predict Melanoma Metastatic Patient Response to Checkpoint Inhibitors". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05649683. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*